Neuralstem Inc. (PALI)

Last Three Months

27-Jan-24 -- 26-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

13

0

7

+1

0

+2

0

+3

Two Year Chart

27-Apr-22 -- 26-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
13-Feb-24 3:08 PM View:	08-Feb-24 Option Exercise 0	Csimma Cristina Director		Neuralstem Inc. - PALI	20645% 62 to 12.86K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 3:08 PM View:	08-Feb-24 Option Exercise 0	Diaz Stephanie Director		Neuralstem Inc. - PALI	100% 0 to 12.8K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 3:08 PM View:	09-Feb-24 Option Exercise 0	Neal James R Director		Neuralstem Inc. - PALI	100% 0 to 10.92K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 3:08 PM View:	08-Feb-24 Option Exercise 0	Trenschel Robert J. Director		Neuralstem Inc. - PALI	100% 0 to 10.92K	0	0	--	--	Show Txns Hide Txns

01-Feb-24 8:30 AM View:	31-Jan-24 Private Purchase $6.05K	Williams Donald Allen Director		Neuralstem Inc. - PALI	50% 20.0K to 30.0K	0	0	--	--	Show Txns Hide Txns

12-Mar-24 6:29 PM View:	11-Mar-24 Option Exercise 0	Finley John David CEO, CFO, Director Director		Neuralstem Inc. - PALI	49% 65.43K to 97.63K	0	0	--	--	Show Txns Hide Txns

08-Feb-24 4:38 PM View:	06-Feb-24 Payment of Exercise ($0.94K)	Jones Mitchell Lawrence Chief Medical Officer		Neuralstem Inc. - PALI	162% 2.92K to 7.66K	0	0	--	--	Show Txns Hide Txns